|Bid||3.2100 x 800|
|Ask||3.2700 x 900|
|Day's Range||3.1850 - 3.3900|
|52 Week Range||2.6100 - 16.1700|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 16, 2022 - Mar 21, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||25.17|
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
WATERTOWN, Mass., August 04, 2022--SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today reported second quarter 2022 financial results and recent portfolio updates.
WATERTOWN, Mass., July 12, 2022--SQZ Biotechnologies Company (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced the publication of a technical review examining the ability of SQZ® Antigen Presenting Cells (APCs) to activate CD8 T cells through MHC-I antigen presentation, an approach that may enable a more powerful T cell response and infiltration into solid tumors. Published in ESMO’s Immuno-Oncology and Technology (IOTECH) jour